Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-25T06:18:43.366Z Has data issue: false hasContentIssue false

3 - Principles of irreversible electroporation

from Section II - Principles of image-guided therapies

Published online by Cambridge University Press:  05 September 2016

Govindarajan Srimathveeravalli
Affiliation:
Department of Radiology
Stephen B. Solomon
Affiliation:
Department of Radiology
Jean-Francois H. Geschwind
Affiliation:
Yale University School of Medicine, Connecticut
Michael C. Soulen
Affiliation:
Department of Radiology, University of Pennsylvania Hospital, Philadelphia
Get access

Summary

Introduction

Electroporation is a phenomenon where cells exposed to a strong external electric field develop nano-scale pores in their plasma membrane. Typically, the pores reseal once the external electric field is removed and the cell continues functioning normally. However, if the number or size of pores formed in the membrane exceeds a certain threshold, the cell is unable to repair the pores, even after removal of the external electric field. This effect has been termed irreversible electroporation (IRE). IRE may be considered a non-thermal ablation technique, as cell death is largely due to electroporation-related factors and is not contingent on sustained changes in temperature. However, this does not completely preclude heating of the treated tissue, as Joule heating-induced damage to tissue during IRE has been seen to occur within a 2–3-mm zone adjacent to the probes. The largely non-thermal mechanism of cell lysis makes IRE an attractive option for the treatment of tumors that are contraindicated for established thermal ablation techniques. As IRE ablation seems unaffected by variations in tissue perfusion and biological heat-sink effects, it has been used to treat hypervascular tumors and lesions adjacent to large blood vessels (Figure 3.1). Unlike thermal ablation techniques, which can denature proteins and completely destroy collagenous structures within the ablation zone, ablation with IRE has been observed to spare the extracellular matrix within the treated regions. This has allowed the safe application of IRE to treat tumors abutting the bile duct or the rectum in patients (Figure 3.1).

IRE presents a new clinical paradigm for the planning and delivery of image-guided ablations. Unlike thermal ablation techniques, where the ablation zone is centered on a single ablation probe, treatment delivery using IRE is typically planned between two monopolar needle electrodes (Figure 3.2). Small variations in the geometry of probe placement can significantly affect the size and shape of the resulting effective ablation zone, affecting the volume of tissue that undergoes destruction (Figure 3.3). The strong electric fields used for IRE ablation can induce neuromuscular activation and affect physiological functions that are sensitive to electrical energy. Therefore, use of IRE in patients has special anesthesia requirements, including the use of a deep paralytic agent to reduce current-induced neuromuscular stimulation.

Type
Chapter
Information
Interventional Oncology
Principles and Practice of Image-Guided Cancer Therapy
, pp. 13 - 19
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Faroja, M, Ahmed, M, Appelbaum, L, et al. Irreversible electroporation ablation: is all the damage nonthermal? Radiology 2013; 266: 462–470.Google Scholar
2. Kingham, TP, Karkar, AM, D'Angelica, MI, et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. Am Coll Surg 2012; 215(3): 379–387.Google Scholar
3. Phillips, M, Maor, E, Rubinsky, B. Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng 2010; 132(9): 091003.Google Scholar
4. Silk, MT, Wimmer, T, Lee, KS, et al. Percutaneous ablation of peribiliary tumors with irreversible electroporation. J Vasc Interv Radiol 2014; 25: 112–118.Google Scholar
5. Deodhar, A, Dickfeld, T, Single, GW, et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR Am J Roentgenol 2011; 196(3): W330–W335.Google Scholar
6. Weaver, JC. Electroporation theory. Concepts and mechanisms. Methods Mol Biol 1995; 55: 3–28.Google Scholar
7. Valic, B, Golzio, M, Pavlin, M, et al. Effect of electric field induced transmembrane potential on spheroidal cells: theory and experiment. Eur Biophys J 2003; 32 (6): 519–528.Google Scholar
8. Ivorra, A. Tissue electroporation as a bioelectric phenomenon: basic concepts. In Rubinsky, B, ed. Irreversible Electroporation. Springer Series in Biomedical Engineering. Berlin: Springer, 2010; pp. 23–61.Google Scholar
9. Gowrishankar, TR, Weaver, JC. An approach to electrical modeling of single and multiple cells. Proc Natl Acad Sci U S A. 2003; 100(6): 3203–3208.CrossRefGoogle Scholar
10. Hui, SW. Effects of pulse length and strength on electroporation efficiency. Methods Mol Biol 1995; 55: 29–40.Google Scholar
11. Golberg, A, Rubinsky, B. A statistical model for multidimensional irreversible electroporation cell death in tissue. Biomed Eng Online 2010; 9: 13.Google Scholar
12. Rubinsky, J, Onik, G, Mikus, P, et al. Optimal parameters for the destruction of prostate cancer using irreversible electroporation. J Urol 2008; 180 (6): 2668–2674.Google Scholar
13. Davalos, RV, Mir, IL, Rubinsky, B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33 (2): 223–231.Google Scholar
14. Daniels, C, Rubinsky, B. Electrical field and temperature model of nonthermal irreversible electroporation in heterogeneous tissues. J Biomech Eng 2009; 131 (7): 071006.Google Scholar
15. Neal, RE 2nd, Davalos, RV. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems. Ann Biomed Eng 2009; 37 (12): 2615–2625.Google Scholar
16. Ben-David, E, Ahmed, M, Faroja, M, et al. Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties. Radiology 2013; 269 (3): 738–747.Google Scholar
17. Wimmer, T, Srimathveeravalli, G, Gutta, N, et al. Comparison of simulation-based treatment planning with imaging and pathology outcomes for percutaneous CT-guided irreversible electroporation of the porcine pancreas: a pilot study. J Vasc Interv Radiol 2013; 24 (11): 1709–1718.Google Scholar
18. Maor, E, Ivorra, A, Mitchell, JJ, et al. Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation. J Vasc Interv Radiol 2010; 21 (11): 1708–1715.Google Scholar
19. Srimathveeravalli, G, Wimmer, T, Monette, S, et al. Evaluation of an endorectal electrode for performing focused irreversible electroporation ablations in the swine rectum. J Vasc Interv Radiol 2013; 24 (8): 1249–1256.Google Scholar
20. Neal, RE 2nd, Singh, R, Hatcher, HC, et al. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res Treat 2010; 123 (1): 295–301.Google Scholar
21. Ivorra, A, Al-Sakere, B, Rubinsky, B, et al. In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome. Phys Med Biol 2009; 54 (19): 5949–5963.Google Scholar
22. Neal, RE 2nd, Garcia, PA, Robertson, JL, et al. Experimental characterization and numerical modeling of tissue electrical conductivity during pulsed electric fields for irreversible electroporation treatment planning. IEEE Trans Biomed Eng 2012; 59 (4): 1076–1085.Google Scholar
23. Neal, RE 2nd, Millar, JL, Kavnoudias, H, et al. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation. Prostate 2014; 74(5): 458–468.Google Scholar
24. Au, JT, Kingham, TP, Jun, K, et al. Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography. Surgery 2013; 153 (6): 787–793.Google Scholar
25. Appelbaum, L, Ben-David, E, Sosna, J, et al. US findings after irreversible electroporation ablation: radiologic–pathologic correlation. Radiology 2012; 262 (1): 117–125.Google Scholar
26. Hjouj, M, Last, D, Guez, D, et al. MRI study on reversible and irreversible electroporation induced blood brain barrier disruption. PLoS ONE 2012; 7 (8): e42817.Google Scholar
27. Wendler, JJ, Porsch, M, Hühne, S, et al. Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model. Cardiovasc Intervent Radiol 2013; 36 (2): 512–520.Google Scholar
28. Zhang, Y, White, SB, Nicolai, JR, et al. Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model. Radiology 2014; 18: 130989.Google Scholar
29. Ryan, ER, Sofocleous, CT, Schöder, H, et al. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology 2013; 268 (1): 288–295.Google Scholar
30. Scheffer, HJ, Nielsen, K, Jong, MC de, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol 2014; pii: S1051–0443(14)00101–8.Google Scholar
31. Cannon, R, Ellis, S, Hayes, D, et al. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 2013; 107 (5): 544–549.Google Scholar
32. Martin, RC 2nd, McFarland, K, Ellis, S, et al. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 2013; 20 Suppl 3: S443–S449.Google Scholar
33. Narayanan, G, Hosein, PJ, Arora, G, et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol 2012; 23 (12): 1613–1621.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×